Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$20K 2238
2023
Q1
$20K Buy
+100,000
New +$1.3M ﹤0.01% 1832

Other funds holding ETNB

Schonfeld Strategic Advisors's ETNB Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 272,094 shares — an estimated $4M sold.

Schonfeld Strategic Advisors first reported a position in ETNB in Q4 2019 and held it in 15 quarters. The position peaked at $6.11M in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 272,094 89bio shares in Q4 2025, an estimated $4M.
  • Schonfeld Strategic Advisors first reported a position in 89bio in Q4 2019 and held it in 15 quarters.
  • Schonfeld Strategic Advisors's 89bio position peaked at $6.11M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.